PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.90%
Net income growth under 50% of MRVL's 6.81%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.16%
Both reduce yoy D&A, with MRVL at -3.59%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-248.39%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-7.02%
Negative yoy SBC while MRVL is 14.10%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
37.95%
Less working capital growth vs. MRVL's 199.20%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-131.82%
AR is negative yoy while MRVL is 54.23%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
46.84%
Some inventory rise while MRVL is negative at -188.94%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
100.00%
Lower AP growth vs. MRVL's 1846.73%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
42.93%
Some yoy usage while MRVL is negative at -89.19%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
No Data
No Data available this quarter, please select a different quarter.
22.29%
Operating cash flow growth at 75-90% of MRVL's 24.90%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-42.27%
Both yoy lines negative, with MRVL at -47.34%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
6.30%
Some yoy expansion while MRVL is negative at -178.34%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-51.33%
We reduce yoy sales while MRVL is 32.70%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-963.49%
Both yoy lines negative, with MRVL at -553.05%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-48.57%
Both yoy lines negative, with MRVL at -34.71%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
41.37%
Buyback growth of 41.37% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.